SEC Form 4 · accession 0001140361-17-024913
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Jun 9, 2017
Accepted (ET)
Jun 13, 2017 · 8:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 9, 2017 | M | 5,464 | $21.51 | A | 79,806 | D | |
| Common Stock | Jun 9, 2017 | M | 3,775 | $26.49 | A | 83,581 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1 | $21.51 | Jun 9, 2017 | M | 5,464 | D | Nov 12, 2010 | May 11, 2020 | Common Stock | 5,464 | 0 | D |
| Stock Option (Right to buy Common Stock)F1 | $26.49 | Jun 9, 2017 | M | 3,775 | D | Nov 12, 2011 | May 11, 2021 | Common Stock | 3,775 | 0 | D |
Explanation of responses
- F1Reflects the number of stock options outstanding after the transaction from this specific stock option grant.